Frontiers in Public Health (Jul 2021)
Integrating Health Systems and Science to Respond to COVID-19 in a Model District of Rural Madagascar
- Rado J. L. Rakotonanahary,
- Herinjaka Andriambolamanana,
- Benedicte Razafinjato,
- Estelle M. Raza-Fanomezanjanahary,
- Vero Ramanandraitsiory,
- Fiainamirindra Ralaivavikoa,
- Andritiana Tsirinomen'ny Aina,
- Lea Rahajatiana,
- Luc Rakotonirina,
- Justin Haruna,
- Laura F. Cordier,
- Megan B. Murray,
- Giovanna Cowley,
- Demetrice Jordan,
- Mark A. Krasnow,
- Mark A. Krasnow,
- Patricia C. Wright,
- Patricia C. Wright,
- Patricia C. Wright,
- Thomas R. Gillespie,
- Thomas R. Gillespie,
- Thomas R. Gillespie,
- Michael Docherty,
- Tara Loyd,
- Michelle V. Evans,
- John M. Drake,
- Calistus N. Ngonghala,
- Calistus N. Ngonghala,
- Calistus N. Ngonghala,
- Michael L. Rich,
- Michael L. Rich,
- Michael L. Rich,
- Stephen J. Popper,
- Stephen J. Popper,
- Ann C. Miller,
- Ann C. Miller,
- Felana A. Ihantamalala,
- Felana A. Ihantamalala,
- Andriamihaja Randrianambinina,
- Bruno Ramiandrisoa,
- Emmanuel Rakotozafy,
- Albert Rasolofomanana,
- Germain Rakotozafy,
- Manuela C. Andriamahatana Vololoniaina,
- Benjamin Andriamihaja,
- Benjamin Andriamihaja,
- Andres Garchitorena,
- Andres Garchitorena,
- Julio Rakotonirina,
- Alishya Mayfield,
- Alishya Mayfield,
- Alishya Mayfield,
- Karen E. Finnegan,
- Karen E. Finnegan,
- Matthew H. Bonds,
- Matthew H. Bonds
Affiliations
- Rado J. L. Rakotonanahary
- PIVOT NGO, Ranomafana, Madagascar
- Herinjaka Andriambolamanana
- PIVOT NGO, Ranomafana, Madagascar
- Benedicte Razafinjato
- PIVOT NGO, Ranomafana, Madagascar
- Estelle M. Raza-Fanomezanjanahary
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Vero Ramanandraitsiory
- PIVOT NGO, Ranomafana, Madagascar
- Fiainamirindra Ralaivavikoa
- PIVOT NGO, Ranomafana, Madagascar
- Andritiana Tsirinomen'ny Aina
- PIVOT NGO, Ranomafana, Madagascar
- Lea Rahajatiana
- PIVOT NGO, Ranomafana, Madagascar
- Luc Rakotonirina
- PIVOT NGO, Ranomafana, Madagascar
- Justin Haruna
- PIVOT NGO, Ranomafana, Madagascar
- Laura F. Cordier
- PIVOT NGO, Ranomafana, Madagascar
- Megan B. Murray
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
- Giovanna Cowley
- PIVOT NGO, Ranomafana, Madagascar
- Demetrice Jordan
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
- Mark A. Krasnow
- Centre Valbio, Ranomafana, Madagascar
- Mark A. Krasnow
- Department of Biochemistry, Stanford University, Stanford, CA, United States
- Patricia C. Wright
- Centre Valbio, Ranomafana, Madagascar
- Patricia C. Wright
- Institute for the Conservation of Tropical Environments, Stony Brook University, Stony Brook, NY, United States
- Patricia C. Wright
- Department of Anthropology, Stony Brook University, Stony Brook, NY, United States
- Thomas R. Gillespie
- Centre Valbio, Ranomafana, Madagascar
- Thomas R. Gillespie
- Department of Environmental Sciences and Program in Population Biology, Ecology, and Evolutionary Biology, Emory University, Atlanta, GA, United States
- Thomas R. Gillespie
- Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States
- Michael Docherty
- Centre Valbio, Ranomafana, Madagascar
- Tara Loyd
- PIVOT NGO, Ranomafana, Madagascar
- Michelle V. Evans
- 0Odum School of Ecology and Center for the Ecology of Infectious Diseases, University of Georgia, Athens, GA, United States
- John M. Drake
- 0Odum School of Ecology and Center for the Ecology of Infectious Diseases, University of Georgia, Athens, GA, United States
- Calistus N. Ngonghala
- 1Department of Mathematics, University of Florida, Gainesville, FL, United States
- Calistus N. Ngonghala
- 2Emerging Pathogens Institute, University of Florida, Gainesville, FL, United States
- Calistus N. Ngonghala
- 3Center for African Studies, University of Florida, Gainesville, FL, United States
- Michael L. Rich
- PIVOT NGO, Ranomafana, Madagascar
- Michael L. Rich
- 4Brigham and Women's Hospital, Boston, MA, United States
- Michael L. Rich
- 5Partners in Health, Boston, MA, United States
- Stephen J. Popper
- PIVOT NGO, Ranomafana, Madagascar
- Stephen J. Popper
- 6Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, United States
- Ann C. Miller
- PIVOT NGO, Ranomafana, Madagascar
- Ann C. Miller
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
- Felana A. Ihantamalala
- PIVOT NGO, Ranomafana, Madagascar
- Felana A. Ihantamalala
- Centre Valbio, Ranomafana, Madagascar
- Andriamihaja Randrianambinina
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Bruno Ramiandrisoa
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Emmanuel Rakotozafy
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Albert Rasolofomanana
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Germain Rakotozafy
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Manuela C. Andriamahatana Vololoniaina
- Madagascar Ministry of Public Health, Antananarivo, Madagascar
- Benjamin Andriamihaja
- PIVOT NGO, Ranomafana, Madagascar
- Benjamin Andriamihaja
- Centre Valbio, Ranomafana, Madagascar
- Andres Garchitorena
- PIVOT NGO, Ranomafana, Madagascar
- Andres Garchitorena
- 7MIVEGEC, Université de Montpellier, CNRS, IRD, Montpellier, France
- Julio Rakotonirina
- 8Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar
- Alishya Mayfield
- PIVOT NGO, Ranomafana, Madagascar
- Alishya Mayfield
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
- Alishya Mayfield
- 4Brigham and Women's Hospital, Boston, MA, United States
- Karen E. Finnegan
- PIVOT NGO, Ranomafana, Madagascar
- Karen E. Finnegan
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
- Matthew H. Bonds
- PIVOT NGO, Ranomafana, Madagascar
- Matthew H. Bonds
- Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States
- DOI
- https://doi.org/10.3389/fpubh.2021.654299
- Journal volume & issue
-
Vol. 9
Abstract
There are many outstanding questions about how to control the global COVID-19 pandemic. The information void has been especially stark in the World Health Organization Africa Region, which has low per capita reported cases, low testing rates, low access to therapeutic drugs, and has the longest wait for vaccines. As with all disease, the central challenge in responding to COVID-19 is that it requires integrating complex health systems that incorporate prevention, testing, front line health care, and reliable data to inform policies and their implementation within a relevant timeframe. It requires that the population can rely on the health system, and decision-makers can rely on the data. To understand the process and challenges of such an integrated response in an under-resourced rural African setting, we present the COVID-19 strategy in Ifanadiana District, where a partnership between Malagasy Ministry of Public Health (MoPH) and non-governmental organizations integrates prevention, diagnosis, surveillance, and treatment, in the context of a model health system. These efforts touch every level of the health system in the district—community, primary care centers, hospital—including the establishment of the only RT-PCR lab for SARS-CoV-2 testing outside of the capital. Starting in March of 2021, a second wave of COVID-19 occurred in Madagascar, but there remain fewer cases in Ifanadiana than for many other diseases (e.g., malaria). At the Ifanadiana District Hospital, there have been two deaths that are officially attributed to COVID-19. Here, we describe the main components and challenges of this integrated response, the broad epidemiological contours of the epidemic, and how complex data sources can be developed to address many questions of COVID-19 science. Because of data limitations, it still remains unclear how this epidemic will affect rural areas of Madagascar and other developing countries where health system utilization is relatively low and there is limited capacity to diagnose and treat COVID-19 patients. Widespread population based seroprevalence studies are being implemented in Ifanadiana to inform the COVID-19 response strategy as health systems must simultaneously manage perennial and endemic disease threats.
Keywords